Few Doctors Would Consider Euthanasia in Psychiatric Disease

This article originally appeared here.
Share this content:
Few Doctors Would Consider Euthanasia in Psychiatric Disease
Few Doctors Would Consider Euthanasia in Psychiatric Disease

WEDNESDAY, Feb. 18, 2015 (HealthDay News) -- Few physicians would find euthanasia and physician-assisted suicide (EAS) conceivable for patients with psychiatric disease, dementia, or those who are "tired of living," according to a study from the Netherlands published online Feb. 18 in the Journal of Medical Ethics.

Eva Elizabeth Bolt, from the VU University Medical Center in Amsterdam, and colleagues examined whether physicians can conceive of granting requests for EAS in patients with cancer, another physical disease, psychiatric disease, dementia, or among those who are tired of living. Data were collected from a cross-sectional survey conducted among 2,269 Dutch general practitioners, elderly care physicians, and clinical specialists (response rate, 64 percent).

The researchers found that most physicians reported that it was conceivable that they would grant an EAS request for a patient with cancer (85 percent) or another physical disease (82 percent). A minority of physicians found it conceivable that they would grant this request in patients with psychiatric disease (34 percent), early-stage dementia (40 percent), advanced dementia (29 to 33 percent), or for those who were tired of living (27 percent). The likelihood of finding it conceivable that they would perform EAS was highest for general practitioners.

"This study shows that a minority of Dutch physicians find it conceivable that they would grant a request for EAS from a patient with psychiatric disease, dementia, or a patient who is tired of living," the authors write.

Abstract
Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »